PT-141 (Bremelanotide)
3.3mg/ml 3mls (10mg vial) $107 [5-20 Injections]
Sexual Wellness | Libido Support | Sexual Arousal | Desire & Intimacy
What Is PT-141?
PT-141, also known as Bremelanotide, is a synthetic peptide that acts on melanocortin receptors in the central nervous system. These receptors are involved in several biological functions, including sexual desire and arousal.
Unlike medications that primarily influence blood flow, PT-141 works through pathways in the brain associated with sexual motivation and response.
PT-141 has attracted attention for its potential applications in sexual wellness, particularly in individuals experiencing reduced sexual desire.
Areas of Research & Potential Benefits
Sexual Desire & Libido
PT-141 has been studied for its effects on sexual desire, particularly in premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
Bremelanotide is FDA-approved under the brand name Vyleesi for this specific condition.
Sexual Arousal
PT-141 activates melanocortin receptors involved in sexual arousal pathways.
Researchers have investigated how these pathways influence sexual motivation and arousal in both men and women.
Female Sexual Wellness
Clinical studies have demonstrated improvements in sexual desire and reductions in distress related to low sexual desire in certain premenopausal women with HSDD.
Unlike hormone replacement therapies, PT-141 does not work by directly increasing estrogen or testosterone levels.
Male Sexual Function Research
PT-141 has also been investigated in men experiencing erectile dysfunction and other sexual function concerns.
Its mechanism differs from medications such as sildenafil and tadalafil, which primarily support erectile function by increasing blood flow.
PT-141 is not FDA-approved for treating erectile dysfunction.
Central Nervous System & Melanocortin Signaling
PT-141 acts on melanocortin receptors involved in neurological pathways associated with sexual behavior and motivation.
Researchers continue to investigate the role of melanocortin signaling in sexual response.
Who Should Avoid PT-141?
Individuals with the following conditions should avoid PT-141 or undergo careful medical evaluation:
-
Uncontrolled high blood pressure: Bremelanotide can temporarily increase blood pressure.
-
Known cardiovascular disease: FDA-approved bremelanotide is contraindicated in individuals with known cardiovascular disease.
-
Pregnancy: PT-141 should be avoided during pregnancy.
-
Breastfeeding: Safety information is insufficient, and medical evaluation is necessary.
-
Individuals taking oral naltrexone: Bremelanotide may reduce the effectiveness of oral naltrexone.
-
Individuals with significant kidney or liver disease: Medical evaluation is recommended because drug exposure may be increased.
-
Individuals with known allergies to bremelanotide or formulation ingredients: Hypersensitivity reactions may occur.
Potential Side Effects
Possible side effects may include:
- Nausea
- Flushing or warmth
- Headaches
- Injection-site reactions
- Vomiting
- Dizziness
- Temporary increases in blood pressure
- Temporary decreases in heart rate
- Darkening of the skin or gums (hyperpigmentation), particularly with repeated use
Nausea is one of the most commonly reported side effects.
Important Information
Bremelanotide is FDA-approved under the brand name Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
It is not FDA-approved for men, postmenopausal women, erectile dysfunction, or general sexual performance enhancement.
Compounded PT-141 formulations are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality.
Ordering Information
Please note: You will not be charged for the peptide when checking out through our website.
Once your order has been submitted, you will receive a follow-up email with additional information regarding the peptide, the consultation process, and the next steps.
All requests are subject to appropriate medical review and applicable prescribing requirements. Submitting an order does not guarantee approval or fulfillment.